Parameswaran Venugopal to Proto-Oncogene Proteins c-myc
This is a "connection" page, showing publications Parameswaran Venugopal has written about Proto-Oncogene Proteins c-myc.
Connection Strength
0.207
-
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
Score: 0.161
-
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers. Blood. 2021 01 21; 137(3):374-386.
Score: 0.046